Anti-IL-1 beta antibody [EPR21086]
- KO Validated
- RabMAb
- Recombinant
- Lab Essentials
- 20ul selling size
- What is this?
4
(2 Reviews)
|
(57 Publications)
Rabbit Recombinant Monoclonal IL-1 beta antibody. Suitable for IP, WB, ICC/IF and reacts with Human samples. Cited in 57 publications.
View Alternative Names
IL1F2, IL1B, Interleukin-1 beta, IL-1 beta, Catabolin
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-IL-1 beta antibody [EPR21086] (AB216995)
Immunohistochemical analysis of 4% paraformaldehyde fixed, 0.1% TritonX-100 permeabilised U-937 (human histiocytic lymphoma monocyte) cells labeling IL-1 beta with ab216995 at 1/50 (10 μg/ml) dilution. Followed by ab150081 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed secondary antibody at 1/1000 (2 μg/ml) dilution. ab195889 Anti-alpha Tubulin mouse monoclonal antibody - Microtubule Marker (Alexa Fluor® 594) was used to counterstain at 1/200 (2.5 μg/ml) dilution. Nuclear staining : DAPI.
Confocal image showing cytoplasmic staining in U-937 cells treated with Phorbol-12-myristate-13-acetate (100 nM) for 2 days, then replaced it with Lipopolysaccharides (1 μg/ml) for 13 h, with addition of Brefeldin A (5 μg/ml) for the last 4 hours.
- IP
Unknown
Immunoprecipitation - Anti-IL-1 beta antibody [EPR21086] (AB216995)
IL-1 beta was immunoprecipitated from 0.35 mg THP-1 (human monocytic leukemia monocyte) whole cell lysate treated with 100 ng/ml lipopolysaccharide (LPS) for 3 hours, with ab216995 at 1/30 dilution. Western blot was performed from the immunoprecipitate using ab216995 at 1/1000 dilution. VeriBlot for IP Detection Reagent (HRP) (ab131366), was used for detection at 1/5000 dilution.
Lane 1 : THP-1 (human monocytic leukemia monocyte) treated with 100 ng/ml lipopolysaccharide (LPS) for 3 hours whole cell lysate 10 μg (Input).
Lane 2 : ab216995 IP in THP-1 treated with 100 ng/ml lipopolysaccharide (LPS) for 3 hours whole cell lysate (+).
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab216995 in THP-1 treated with 100 ng/ml lipopolysaccharide (LPS) for 3 hours whole cell lysate (-).
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
Exposure time : 3 minutes.
All lanes:
Immunoprecipitation - Anti-IL-1 beta antibody [EPR21086] (ab216995)
Predicted band size: 30 kDa
false
- WB
Unknown
Western blot - Anti-IL-1 beta antibody [EPR21086] (AB216995)
Blocking/Dilution buffer and concentration : 5% NFDM/TBST.
The expression profile is consistent with the literature (PMID 15192144 and 10845914).
All lanes:
Western blot - Anti-IL-1 beta antibody [EPR21086] (ab216995) at 1/1000 dilution
Lane 1:
Untreated THP-1 (human monocytic leukemia monocyte) whole cell lysate at 20 µg
Lane 2:
THP-1 treated with 100 ng/ml Lipopolysaccharide (LPS) for 3 hours at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 30 kDa
true
Exposure time: 3min
- WB
Lab
Western blot - Anti-IL-1 beta antibody [EPR21086] (AB216995)
Lanes 1 - 4 : Merged signal (red and green). Green - ab216995 observed at 27-32 kDa. Red - loading control ab7291 (Mouse anti-Alpha Tubulin [DM1A]) observed at 55 kDa.
ab216995 was shown to react with IL-1 beta in LPS-treated wild-type THP-1 cells in Western blot with loss of signal observed in IL1B knockout cell line ab273762 (LPS-treated) (knockout cell lysate ab275508). Wild-type THP-1 and IL1B knockout cell lysates were subjected to SDS-PAGE. Membranes were blocked in 3 % milk in TBS-T (0.1 % Tween®) before incubation with ab216995 and ab7291 (Mouse anti-Alpha Tubulin [DM1A]) overnight at 4 °C at a 1 in 1000 dilution and a 1 in 20000 dilution respectively. Blots were incubated with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 h at room temperature before imaging.
All lanes:
Western blot - Anti-IL-1 beta antibody [EPR21086] (ab216995) at 1/1000 dilution
Lane 1:
Wild-type THP-1 untreated cell lysate at 30 µg
Lane 2:
Wild-type THP-1 LPS-treated (3 h, 100 ng/ml) cell lysate at 30 µg
Lane 2:
Western blot - Human IL1B knockout THP-1 cell line (<a href='/en-us/products/cell-lines/human-il1b-knockout-thp-1-cell-line-ab273762'>ab273762</a>)
Lane 3:
IL1B knockout THP-1 untreated cell lysate at 30 µg
Lane 4:
IL1B knockout THP-1 LPS-treated (3 h, 100 ng/ml) cell lysate at 30 µg
Predicted band size: 30 kDa
Observed band size: 27-32 kDa
false
Related conjugates and formulations (1)
-
Anti-IL-1 beta antibody [EPR21086] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (57)
Recent publications for all applications. Explore the full list and refine your search
Food science & nutrition 13:e70688 PubMed40755501
2025
Applications
Unspecified application
Species
Unspecified reactive species
Journal of neuroinflammation 22:190 PubMed40684214
2025
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 16:6074 PubMed40603850
2025
Applications
Unspecified application
Species
Unspecified reactive species
Inflammation : PubMed40372612
2025
Applications
Unspecified application
Species
Unspecified reactive species
Materials today. Bio 31:101482 PubMed39944531
2025
Applications
Unspecified application
Species
Unspecified reactive species
International heart journal 65:1087-1094 PubMed39537169
2024
Applications
Unspecified application
Species
Unspecified reactive species
Toxicology research 13:tfae115 PubMed39100861
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cellular and molecular biology (Noisy-le-Grand, France) 70:85-91 PubMed38836676
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cell proliferation 57:e13663 PubMed38803043
2024
Applications
Unspecified application
Species
Unspecified reactive species
Biomaterials research 28:0013 PubMed38617751
2024
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com